Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 457 Name doxybactin
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Doxybactin vet 50 mg V/DCP/17/0031 Dechra Regulatory B.V., Nīderlande QJ01AA02 dogs; cats

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycyclin hyclate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 26-Aug-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0031-01 50 mg 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0031-02 50 mg 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0031-03 50 mg 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0031-04 50 mg 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0031-05 50 mg 10 Kastīte ar blisteri, 10 tablete -
Doxybactin vet 200 mg V/DCP/17/0032 Dechra Regulatory B.V., Nīderlande QJ01AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycyclin hyclate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 26-Aug-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0032-01 200 mg 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0032-02 200 mg 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0032-03 200 mg 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0032-04 200 mg 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0032-05 200 mg 10 Kastīte ar blisteri, 10 tablete -
Doxybactin vet 400 mg V/DCP/17/0033 Dechra Regulatory B.V., Nīderlande QJ01AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycyclin hyclate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 26-Aug-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0033-01 400 mg 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0033-02 400 mg 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0033-03 400 mg 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0033-04 400 mg 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0033-05 400 mg 10 Kastīte ar blisteri, 10 tablete -
Doxybactin 50 mg V/I/20/0061 Dechra Regulatory B.V., Nīderlande QJ01AA02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycycline
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;Genera d.d., Horvātija
Date of authorisation/renewal: 24-Nov-2025
Marketing authorisation valid until: 23-Nov-2030
Marketing authorisation procedure: I
Package leaflet: [DOCX] 24112025_LI (24-Nov-2025)
Labelling text: See products section
Summary of product characteristics: -

Products

ID Strength Package size Primary packaging Labelling
V/I/20/0061-01 50 mg 1 alumīnija/PVC/PE/PVDC blisteris, 10 tablete [PDF]

4 records · Download

  • 1